Royal Bank of Canada’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11K | Buy |
861
+802
| +1,359% | +$10.3K | ﹤0.01% | 6647 |
|
|
2026
Q1 | $1K | Sell |
59
-279
| -83% | -$4.29K | ﹤0.01% | 6963 |
|
|
2025
Q4 | $6K | Buy |
338
+66
| +24% | +$1.22K | ﹤0.01% | 6668 |
|
|
2025
Q3 | $6K | Sell |
272
-366
| -57% | -$13.6K | ﹤0.01% | 6669 |
|
|
2025
Q2 | $22K | Sell |
638
-33,515
| -98% | -$878K | ﹤0.01% | 6233 |
|
|
2025
Q1 | $610K | Buy |
+34,153
| New | +$692K | ﹤0.01% | 3847 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7440 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7534 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7593 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7586 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7599 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7723 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7863 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7716 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7130 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6576 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6487 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6451 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6782 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6886 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6978 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6759 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6815 |
|
|
2016
Q4 | – | Hold |
0
| – | -$3K | – | 6774 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6106 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5439 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5054 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4592 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4605 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4263 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4268 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4358 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4075 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3754 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 4092 |
|
Other funds holding TNXP
JHC
II
Royal Bank of Canada's TNXP Position: Q2 2026 in Review
Royal Bank of Canada increased its Tonix Pharmaceuticals (TNXP) stake by 1,359% in Q2 2026, buying an estimated $10.3K and bringing the position to 861 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #6647.
Royal Bank of Canada first reported a position in TNXP in Q1 2025 and has held it in 6 quarters since. The position peaked at $610K in Q1 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.
- Royal Bank of Canada held 861 shares of Tonix Pharmaceuticals worth $11K as of Q2 2026.
- Royal Bank of Canada bought 802 Tonix Pharmaceuticals shares in Q2 2026, an estimated $10.3K.
- Tonix Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6647 holding.
- Royal Bank of Canada first reported a position in Tonix Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Royal Bank of Canada's Tonix Pharmaceuticals position peaked at $610K in Q1 2025.
- 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.